Zanubrutinib
Obinutuzumab
(Update) Acalabrutinib in CLL and MCL
Acalabrutinib
ASH: COVID-19 Resources for Managing Blood Cancers
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
Patient Power
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic